Report: AstraZeneca, Pfizer, Novartis home in on Onyx bids

AstraZeneca, Novartis and Pfizer are still in the hunt for Onyx Pharmaceuticals, Bloomberg's sources say. And Amgen, which triggered the whole bidding process with an unsolicited offer last month, hasn't given up either.